<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34830352</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>22</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>18</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">12470</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms222212470</ELocationID><Abstract><AbstractText>Recent research has provided strong evidence that neurodegeneration may develop from an imbalance between synaptic structural components in the brain. Lately, inhibitory synapses communicating via the neurotransmitters GABA or glycine have come to the center of attention. Increasing evidence suggests that imbalance in the structural composition of inhibitory synapses affect deeply the ability of neurons to communicate effectively over synaptic connections. Progressive failure of synaptic plasticity and memory are thus hallmarks of neurodegenerative diseases. In order to prove that structural changes at synapses contribute to neurodegeneration, we need to visualize single-molecule interactions at synaptic sites in an exact spatial and time frame. This visualization has been restricted in terms of spatial and temporal resolution. New developments in electron microscopy and super-resolution microscopy have improved spatial and time resolution tremendously, opening up numerous possibilities. Here we critically review current and recently developed methods for high-resolution visualization of inhibitory synapses in the context of neurodegenerative diseases. We present advantages, strengths, weaknesses, and current limitations for selected methods in research, as well as present a future perspective. A range of new options has become available that will soon help understand the involvement of inhibitory synapses in neurodegenerative disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Radulovi&#x107;</LastName><ForeName>Snje&#x17e;ana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6791-8620</Identifier><AffiliationInfo><Affiliation>Gottfried Schatz Research Center, Division of Cell Biology, Histology and Embryology, Medical University of Graz, 8010 Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunkara</LastName><ForeName>Sowmya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9333-475X</Identifier><AffiliationInfo><Affiliation>Gottfried Schatz Research Center, Division of Cell Biology, Histology and Embryology, Medical University of Graz, 8010 Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maurer</LastName><ForeName>Christa</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7681-2134</Identifier><AffiliationInfo><Affiliation>Gottfried Schatz Research Center, Division of Macroscopic and Clinical Anatomy, Medical University of Graz, 8010 Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leitinger</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5281-9830</Identifier><AffiliationInfo><Affiliation>Gottfried Schatz Research Center, Division of Cell Biology, Histology and Embryology, Medical University of Graz, 8010 Graz, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P 29370</GrantID><Acronym>FWF_</Acronym><Agency>Austrian Science Fund FWF</Agency><Country>Austria</Country></Grant><Grant><GrantID>P 29370</GrantID><Agency>FWF Austrian Science Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018377">Neurotransmitter Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>46627O600J</RegistryNumber><NameOfSubstance UI="D007980">Levodopa</NameOfSubstance></Chemical><Chemical><RegistryNumber>W8O17SJF3T</RegistryNumber><NameOfSubstance UI="D008559">Memantine</NameOfSubstance></Chemical><Chemical><RegistryNumber>Z9O08YRN8O</RegistryNumber><NameOfSubstance UI="D013747">Tetrabenazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008559" MajorTopicYN="N">Memantine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018377" MajorTopicYN="N">Neurotransmitter Agents</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013747" MajorTopicYN="N">Tetrabenazine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">EM</Keyword><Keyword MajorTopicYN="N">SIM</Keyword><Keyword MajorTopicYN="N">STED</Keyword><Keyword MajorTopicYN="N">STORM</Keyword><Keyword MajorTopicYN="N">inhibitory synapse</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">synaptic plasticity</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34830352</ArticleId><ArticleId IdType="pmc">PMC8623765</ArticleId><ArticleId IdType="doi">10.3390/ijms222212470</ArticleId><ArticleId IdType="pii">ijms222212470</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Batool S., Raza H., Zaidi J., Riaz S., Hasan S., Syed N.I. Synapse formation: From cellular and molecular mechanisms to neurodevelopmental and neurodegenerative disorders. J. Neurophysiol. 2019;121:1381&#x2013;1397. doi: 10.1152/jn.00833.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00833.2018</ArticleId><ArticleId IdType="pubmed">30759043</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer&#x2019;s disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991;30:572&#x2013;580. doi: 10.1002/ana.410300410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410300410</ArticleId><ArticleId IdType="pubmed">1789684</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakroborty S., Hill E.S., Christian D.T., Helfrich R., Riley S., Schneider C., Kapecki N., Mustaly-Kalimi S., Seiler F.A., Peterson D.A., et al. Reduced presynaptic vesicle stores mediate cellular and network plasticity defects in an early-stage mouse model of Alzheimer&#x2019;s disease. Mol. Neurodegener. 2019;14:7. doi: 10.1186/s13024-019-0307-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0307-7</ArticleId><ArticleId IdType="pmc">PMC6343260</ArticleId><ArticleId IdType="pubmed">30670054</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson J., Jambrina E., Li J., Marston H., Menzies F., Phillips K., Gilmour G. Targeting the synapse in Alzheimer&#x2019;s disease. Front. Neurosci. 2019;13:735. doi: 10.3389/fnins.2019.00735.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00735</ArticleId><ArticleId IdType="pmc">PMC6664030</ArticleId><ArticleId IdType="pubmed">31396031</ArticleId></ArticleIdList></Reference><Reference><Citation>Mele M., Leal G., Duarte C.B. Role of GABAAR trafficking in the plasticity of inhibitory synapses. J. Neurochem. 2016;139:997&#x2013;1018. doi: 10.1111/jnc.13742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13742</ArticleId><ArticleId IdType="pubmed">27424566</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C.R., Bennett D.A., Blennow K., Carrillo M.C., Dunn B., Haeberlein S.B., Holtzman D.M., Jagust W., Jessen F., Karlawish J., et al. NIA-AA research framework: Toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14:535&#x2013;562. doi: 10.1016/j.jalz.2018.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P., Blennow K., Breteler M.M.B., de Strooper B., Frisoni G.B., Salloway S., Van der Flier W.M. Alzheimer&#x2019;s disease. Lancet. 2016;388:505&#x2013;517. doi: 10.1016/S0140-6736(15)01124-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)01124-1</ArticleId><ArticleId IdType="pubmed">26921134</ArticleId></ArticleIdList></Reference><Reference><Citation>Budak M., Zochowski M. Synaptic failure differentially affects pattern formation in heterogenous networks. Front. Neural Circuits. 2019;13:31. doi: 10.3389/fncir.2019.00031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2019.00031</ArticleId><ArticleId IdType="pmc">PMC6519395</ArticleId><ArticleId IdType="pubmed">31139055</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimojo M., Takuwa H., Takado Y., Tokunaga M., Tsukamoto S., Minatohara K., Ono M., Seki C., Maeda J., Urushihata T., et al. Selective disruption of inhibitory synapses leading to neuronal hyperexcitability at an early stage of tau pathogenesis in a mouse model. J. Neurosci. 2020;40:3491&#x2013;3501. doi: 10.1523/JNEUROSCI.2880-19.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2880-19.2020</ArticleId><ArticleId IdType="pmc">PMC7178904</ArticleId><ArticleId IdType="pubmed">32265258</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim J.A., Canas P.M., Tom&#xe9; A.R., Rolo A.P., Agostinho P., Palmeira C.M., Cunha R.A. Mitochondria in excitatory and inhibitory synapses have similar susceptibility to amyloid-&#x3b2; peptides modeling alzheimer&#x2019;s disease. J. Alzheimers Dis. 2017;60:525&#x2013;536. doi: 10.3233/JAD-170356.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170356</ArticleId><ArticleId IdType="pubmed">28869472</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae J.R., Kim S.H. Synapses in neurodegenerative diseases. BMB Rep. 2017;50:237&#x2013;246. doi: 10.5483/BMBRep.2017.50.5.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2017.50.5.038</ArticleId><ArticleId IdType="pmc">PMC5458673</ArticleId><ArticleId IdType="pubmed">28270301</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravorty A., Jetto C.T., Manjithaya R. Dysfunctional mitochondria and mitophagy as drivers of Alzheimer&#x2019;s disease pathogenesis. Front. Aging Neurosci. 2019;11:311. doi: 10.3389/fnagi.2019.00311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00311</ArticleId><ArticleId IdType="pmc">PMC6880761</ArticleId><ArticleId IdType="pubmed">31824296</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeneweg F.L., Trattnig C., Kuhse J., Nawrotzki R.A., Kirsch J. Gephyrin: A key regulatory protein of inhibitory synapses and beyond. Histochem. Cell Biol. 2018;150:489&#x2013;508. doi: 10.1007/s00418-018-1725-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-018-1725-2</ArticleId><ArticleId IdType="pubmed">30264265</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulijewicz-Nawrot M., Sykov&#xe1; E., Chv&#xe1;tal A., Verkhratsky A., Rodr&#xed;guez J.J. Astrocytes and glutamate homoeostasis in Alzheimer&#x2019;s disease: A decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex. ASN Neuro. 2013;5:273&#x2013;282. doi: 10.1042/AN20130017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/AN20130017</ArticleId><ArticleId IdType="pmc">PMC3791522</ArticleId><ArticleId IdType="pubmed">24059854</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Zhu K., Li N., Wang X., Xiao X., Li L., Li L., He Y., Zhang J., Wo J., et al. Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model. Alzheimers Res. Ther. 2021;13:114. doi: 10.1186/s13195-021-00859-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00859-8</ArticleId><ArticleId IdType="pmc">PMC8204558</ArticleId><ArticleId IdType="pubmed">34127063</ArticleId></ArticleIdList></Reference><Reference><Citation>Limon A., Reyes-Ruiz J.M., Miledi R. Loss of functional GABA A receptors in the Alzheimer diseased brain. Proc. Natl. Acad. Sci. USA. 2012;109:10071&#x2013;10076. doi: 10.1073/pnas.1204606109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1204606109</ArticleId><ArticleId IdType="pmc">PMC3382476</ArticleId><ArticleId IdType="pubmed">22691495</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno H., Yu E., Pigino G., Hernandez A.I., Kim N., Moreira J.E., Sugimori M., Llin&#xe1;s R.R. Synaptic transmission block by presynaptic injection of oligomeric amyloid beta. Proc. Natl. Acad. Sci. USA. 2009;106:5901&#x2013;5906. doi: 10.1073/pnas.0900944106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900944106</ArticleId><ArticleId IdType="pmc">PMC2659170</ArticleId><ArticleId IdType="pubmed">19304802</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickett E.K., Koffie R.M., Wegmann S., Henstridge C.M., Herrmann A.G., Colom-Cadena M., Lleo A., Kay K.R., Vaught M., Soberman R., et al. Non-fibrillar oligomeric amyloid-&#x3b2; within synapses. J. Alzheimers Dis. 2016;53:787&#x2013;800. doi: 10.3233/JAD-160007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160007</ArticleId><ArticleId IdType="pubmed">27258414</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;nnies E., Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer&#x2019;s disease. J. Alzheimers Dis. 2017;57:1105&#x2013;1121. doi: 10.3233/JAD-161088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-161088</ArticleId><ArticleId IdType="pmc">PMC5409043</ArticleId><ArticleId IdType="pubmed">28059794</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Zhao M., Han Y., Zhang H. GABAergic inhibitory interneuron deficits in Alzheimer&#x2019;s disease: Implications for treatment. Front. Neurosci. 2020;14:660. doi: 10.3389/fnins.2020.00660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00660</ArticleId><ArticleId IdType="pmc">PMC7344222</ArticleId><ArticleId IdType="pubmed">32714136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Xiong B.R., Zhang L.Q., Huang X., Yuan X., Tian Y.K., Tian X.B. The role of the GABAergic system in diseases of the central nervous system. Neuroscience. 2021;470:88&#x2013;99. doi: 10.1016/j.neuroscience.2021.06.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2021.06.037</ArticleId><ArticleId IdType="pubmed">34242730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurucu H., Colom-Cadena M., Davies C., Wilkins L., King D., Rose J., Tzioras M., Tulloch J.H., Smith C., Spires-Jones T.L. Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer&#x2019;s disease. Eur. J. Neurol. 2021 doi: 10.1111/ene.15043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15043</ArticleId><ArticleId IdType="pubmed">34331352</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickett E.K., Herrmann A.G., McQueen J., Abt K., Dando O., Tulloch J., Jain P., Dunnett S., Sohrabi S., Fjeldstad M.P., et al. Amyloid beta and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer&#x2019;s disease. Cell Rep. 2019;29:3592&#x2013;3604.e5. doi: 10.1016/j.celrep.2019.11.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.11.044</ArticleId><ArticleId IdType="pmc">PMC6915767</ArticleId><ArticleId IdType="pubmed">31825838</ArticleId></ArticleIdList></Reference><Reference><Citation>Will&#xe9;n K., Sroka A., Takahashi R.H., Gouras G.K. Heterogeneous association of Alzheimer&#x2019;s disease-linked amyloid-&#x3b2; and amyloid-&#x3b2; protein precursor with synapses. J. Alzheimers Dis. 2017;60:511&#x2013;524. doi: 10.3233/JAD-170262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170262</ArticleId><ArticleId IdType="pmc">PMC5611798</ArticleId><ArticleId IdType="pubmed">28869466</ArticleId></ArticleIdList></Reference><Reference><Citation>Folch J., Busquets O., Ettcheto M., S&#xe1;nchez-L&#xf3;pez E., Castro-Torres R.D., Verdaguer E., Garcia M.L., Olloquequi J., Casades&#xfa;s G., Beas-Zarate C., et al. Memantine for the treatment of dementia: A review on its current and future applications. J. Alzheimers Dis. 2018;62:1223&#x2013;1240. doi: 10.3233/JAD-170672.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170672</ArticleId><ArticleId IdType="pmc">PMC5870028</ArticleId><ArticleId IdType="pubmed">29254093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong N.J., Dibb R., Bulk M., van der Weerd L., Liu C. Imaging beta amyloid aggregation and iron accumulation in Alzheimer&#x2019;s disease using quantitative susceptibility mapping MRI. NeuroImage. 2019;191:176&#x2013;185. doi: 10.1016/j.neuroimage.2019.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2019.02.019</ArticleId><ArticleId IdType="pubmed">30739060</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoupi L., Booker S.A., Eigel D., Werner C., Kind P.C., Spires-Jones T.L., Newland B., Williams A.C. Selective vulnerability of inhibitory networks in multiple sclerosis. Acta Neuropathol. 2021;141:415&#x2013;429. doi: 10.1007/s00401-020-02258-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02258-z</ArticleId><ArticleId IdType="pmc">PMC7882577</ArticleId><ArticleId IdType="pubmed">33449171</ArticleId></ArticleIdList></Reference><Reference><Citation>Bos M.A.J.V.d., Higashihara M., Geevasinga N., Menon P., Kiernan M.C., Vucic S. Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS. Neurology. 2018;91:e1669&#x2013;e1676. doi: 10.1212/WNL.0000000000006438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006438</ArticleId><ArticleId IdType="pubmed">30282772</ArticleId></ArticleIdList></Reference><Reference><Citation>Diana A., Pillai R., Bongioanni P., O&#x2019;Keeffe A.G., Miller R.G., Moore D.H. Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst. Rev. 2017;1:CD006049. doi: 10.1002/14651858.CD006049.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006049.pub2</ArticleId><ArticleId IdType="pmc">PMC6953368</ArticleId><ArticleId IdType="pubmed">28067943</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Z., Yang H., Xiao Y., Zhao G., Huang H. The gamma-aminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in rat nucleus accumbens. Behav. Brain Funct. 2012;8:20. doi: 10.1186/1744-9081-8-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1744-9081-8-20</ArticleId><ArticleId IdType="pmc">PMC3393629</ArticleId><ArticleId IdType="pubmed">22559224</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedict R.H.B., Amato M.P., DeLuca J., Geurts J.J.G. Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues. Lancet Neurol. 2020;19:860&#x2013;871. doi: 10.1016/S1474-4422(20)30277-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30277-5</ArticleId><ArticleId IdType="pmc">PMC10011205</ArticleId><ArticleId IdType="pubmed">32949546</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini G., Giovane C.D., Vacchi L., D&#x2019;Amico R., Pietrantonj C.D., Beecher D., Salanti G. Immunomodulators and immunosuppressants for multiple sclerosis: A network meta-analysis. Cochrane Database Syst. Rev. 2011;6:CD008933. doi: 10.1002/14651858.CD008933.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008933.pub2</ArticleId><ArticleId IdType="pubmed">23744561</ArticleId></ArticleIdList></Reference><Reference><Citation>Jasek &#x141;., &#x15a;migielski J., Siger M. Late onset multiple sclerosis&#x2014;Multiparametric MRI characteristics. Neurol. Neurochir. Pol. 2020;54:265&#x2013;271. doi: 10.5603/PJNNS.a2020.0036.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/PJNNS.a2020.0036</ArticleId><ArticleId IdType="pubmed">32368786</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaskow B.J., Baecher-Allan C. Effector T cells in multiple sclerosis. Cold Spring Harb. Perspect. Med. 2018;8:a029025. doi: 10.1101/cshperspect.a029025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a029025</ArticleId><ArticleId IdType="pmc">PMC5880159</ArticleId><ArticleId IdType="pubmed">29358315</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziemssen T., Akg&#xfc;n K., Br&#xfc;ck W. Molecular biomarkers in multiple sclerosis. J. Neuroinflamm. 2019;16:272. doi: 10.1186/s12974-019-1674-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1674-2</ArticleId><ArticleId IdType="pmc">PMC6929340</ArticleId><ArticleId IdType="pubmed">31870389</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Mitchell J.D., Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Cochrane Database Syst Rev. 2012;3:CD001447. doi: 10.1002/14651858.CD001447.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447.pub3</ArticleId><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama A., Saitoh A., Yamada M., Oka J.I., Yamada M. Administration of riluzole into the basolateral amygdala has an anxiolytic-like effect and enhances recognition memory in the rat. Behav. Brain Res. 2017;327:98&#x2013;102. doi: 10.1016/j.bbr.2017.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2017.03.035</ArticleId><ArticleId IdType="pubmed">28359884</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchi E., Bonetto V., Sorar&#xf9; G., Martinelli I., Parchi P., Liguori R., Mandrioli J. Neurofilaments in motor neuron disorders: Towards promising diagnostic and prognostic biomarkers. Mol. Neurodegener. 2020;15:58. doi: 10.1186/s13024-020-00406-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00406-3</ArticleId><ArticleId IdType="pmc">PMC7559190</ArticleId><ArticleId IdType="pubmed">33059698</ArticleId></ArticleIdList></Reference><Reference><Citation>Garret M., Du Z., Chazalon M., Cho Y.H., Baufreton J. Alteration of GABAergic neurotransmission in Huntington&#x2019;s disease. CNS Neurosci. Ther. 2018;24:292&#x2013;300. doi: 10.1111/cns.12826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12826</ArticleId><ArticleId IdType="pmc">PMC6490108</ArticleId><ArticleId IdType="pubmed">29464851</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu Y.-T., Chang Y.-G., Chern Y. Insights into GABAAergic system alteration in Huntington&#x2019;s disease. Open Biol. 2018;8:180165. doi: 10.1098/rsob.180165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.180165</ArticleId><ArticleId IdType="pmc">PMC6303784</ArticleId><ArticleId IdType="pubmed">30518638</ArticleId></ArticleIdList></Reference><Reference><Citation>McColgan P., Tabrizi S.J. Huntington&#x2019;s disease: A clinical review. Eur. J. Neurol. 2018;25:24&#x2013;34. doi: 10.1111/ene.13413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13413</ArticleId><ArticleId IdType="pubmed">28817209</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosas-Arellano A., Tejeda-Guzm&#xe1;n C., Lorca-Ponce E., Palma-Tirado L., Mantellero C.A., Rojas P., Missirlis F., Castro M.A. Huntington&#x2019;s disease leads to decrease of GABA-A tonic subunits in the D2 neostriatal pathway and their relocalization into the synaptic cleft. Neurobiol. Dis. 2018;110:142&#x2013;153. doi: 10.1016/j.nbd.2017.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.11.010</ArticleId><ArticleId IdType="pubmed">29196217</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyant K.J., Ridder A.J., Dayalu P. Huntington&#x2019;s disease&#x2014;Update on treatments. Curr. Neurol. Neurosci. Rep. 2017;17:33. doi: 10.1007/s11910-017-0739-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-017-0739-9</ArticleId><ArticleId IdType="pubmed">28324302</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbe E. Beitr&#xe4;ge zur Theorie des Mikroskops und der mikroskopischen Wahrnehmung. Arch. F&#xfc;r Mikrosk. Anat. 1873;9:413&#x2013;468. doi: 10.1007/BF02956173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02956173</ArticleId></ArticleIdList></Reference><Reference><Citation>Klemann C.J., Roubos E.W. The gray area between synapse structure and function-Gray&#x2019;s synapse types I and II revisited. Synapse. 2011;65:1222&#x2013;1230. doi: 10.1002/syn.20962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/syn.20962</ArticleId><ArticleId IdType="pubmed">21656572</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhang Y., Peng Y., Zhao Z., Zhou Y., Wang X., Peng Y. Protective effect of potassium 2-(l-hydroxypentyl)-benzoate on hippocampal neurons, synapses and dystrophic axons in APP/PS1 mice. Psychopharmacology. 2019;236:2761&#x2013;2771. doi: 10.1007/s00213-019-05251-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-019-05251-x</ArticleId><ArticleId IdType="pubmed">31165206</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterio D.C. The unbiased estimation of number and sizes of arbitrary particles using the disector. J. Microsc. 1984;134:127&#x2013;136. doi: 10.1111/j.1365-2818.1984.tb02501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2818.1984.tb02501.x</ArticleId><ArticleId IdType="pubmed">6737468</ArticleId></ArticleIdList></Reference><Reference><Citation>Napper R.M.A. Total number is important: Using the disector method in design-based stereology to understand the structure of the rodent brain. Front. Neuroanat. 2018;12:16. doi: 10.3389/fnana.2018.00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2018.00016</ArticleId><ArticleId IdType="pmc">PMC5844935</ArticleId><ArticleId IdType="pubmed">29556178</ArticleId></ArticleIdList></Reference><Reference><Citation>Omelchenko N., Roy P., Balcita-Pedicino J.J., Poloyac S., Sesack S.R. Impact of prenatal nicotine on the structure of midbrain dopamine regions in the rat. Brain Struct. Funct. 2016;221:1939&#x2013;1953. doi: 10.1007/s00429-015-1014-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-015-1014-y</ArticleId><ArticleId IdType="pubmed">25716298</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichmann F., Painsipp E., Holzer P., Kummer D., Bock E., Leitinger G. A novel unbiased counting method for the quantification of synapses in the mouse brain. J. Neurosci. Methods. 2015;240:13&#x2013;21. doi: 10.1016/j.jneumeth.2014.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2014.10.020</ArticleId><ArticleId IdType="pmc">PMC4282307</ArticleId><ArticleId IdType="pubmed">25445248</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichmann F., Wegerer V., Jain P., Mayerhofer R., Hassan A.M., Frohlich E.E., Bock E., Pritz E., Herzog H., Holzer P., et al. Environmental enrichment induces behavioural disturbances in neuropeptide Y knockout mice. Sci. Rep. 2016;6:28182. doi: 10.1038/srep28182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28182</ArticleId><ArticleId IdType="pmc">PMC4910086</ArticleId><ArticleId IdType="pubmed">27305846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardalan M., Wegener G., Polsinelli B., Madsen T.M., Nyengaard J.R. Neurovascular plasticity of the hippocampus one week after a single dose of ketamine in genetic rat model of depression. Hippocampus. 2016;26:1414&#x2013;1423. doi: 10.1002/hipo.22617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.22617</ArticleId><ArticleId IdType="pubmed">27440163</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardalan M., Wegener G., Rafati A.H., Nyengaard J.R. S-ketamine rapidly reverses synaptic and vascular deficits of hippocampus in genetic animal model of depression. Int. J. Neuropsychopharmacol. 2017;20:247&#x2013;256. doi: 10.1093/ijnp/pyw098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ijnp/pyw098</ArticleId><ArticleId IdType="pmc">PMC5408982</ArticleId><ArticleId IdType="pubmed">27815416</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.Y., He Y.N., Zhu N., Peng B. Metformin attenuates increase of synaptic number in the rat spinal dorsal horn with painful diabetic neuropathy induced by type 2 diabetes: A stereological study. Neurochem. Res. 2018;43:2232&#x2013;2239. doi: 10.1007/s11064-018-2642-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2642-4</ArticleId><ArticleId IdType="pubmed">30306321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.W., Oh S.H., Lee S.J., Na J.E., Rhyu I.J. Differential synapse density between Purkinje cell dendritic spine and parallel fiber varicosity in the rat cerebellum among the phylogenic lobules. Appl. Microsc. 2020;50:6. doi: 10.1186/s42649-020-00027-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42649-020-00027-6</ArticleId><ArticleId IdType="pmc">PMC7818350</ArticleId><ArticleId IdType="pubmed">33580287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohgomori T., Iinuma K., Yamada J., Jinno S. A unique subtype of ramified microglia associated with synapses in the rat hippocampus. Eur. J. Neurosci. 2021;54:4740&#x2013;4754. doi: 10.1111/ejn.15330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.15330</ArticleId><ArticleId IdType="pubmed">34110047</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray E.G. Axo-somatic and axo-dendritic synapses of the cerebral cortex: An electron microscope study. J. Anat. 1959;93:420&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1244535</ArticleId><ArticleId IdType="pubmed">13829103</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao C.L., Liu Y.T., Sun R., Zhang B., Qi L., Shivakoti S., Tian C.L., Zhang P., Lau P.M., Zhou Z.H., et al. Differentiation and characterization of excitatory and inhibitory synapses by cryo-electron tomography and correlative microscopy. J. Neurosci. 2018;38:1493&#x2013;1510. doi: 10.1523/JNEUROSCI.1548-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1548-17.2017</ArticleId><ArticleId IdType="pmc">PMC5815350</ArticleId><ArticleId IdType="pubmed">29311144</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubochet J. High-pressure freezing for cryoelectron microscopy. Trends Cell Biol. 1995;5:366&#x2013;368. doi: 10.1016/S0962-8924(00)89071-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(00)89071-6</ArticleId><ArticleId IdType="pubmed">14732080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sele M., Wernitznig S., Lipovsek S., Radulovic S., Haybaeck J., Birkl-Toeglhofer A.M., Wodlej C., Kleinegger F., Sygulla S., Leoni M., et al. Optimization of ultrastructural preservation of human brain for transmission electron microscopy after long post-mortem intervals. Acta Neuropathol. Commun. 2019;7:144. doi: 10.1186/s40478-019-0794-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0794-3</ArticleId><ArticleId IdType="pmc">PMC6724377</ArticleId><ArticleId IdType="pubmed">31481118</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Liu Q., Davis M.W., Hollopeter G., Thomas N., Jorgensen N.B., Jorgensen E.M. Ultrafast endocytosis at Caenorhabditis elegans neuromuscular junctions. eLife. 2013;2:e00723. doi: 10.7554/eLife.00723.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.00723</ArticleId><ArticleId IdType="pmc">PMC3762212</ArticleId><ArticleId IdType="pubmed">24015355</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Rost B.R., Camacho-Perez M., Davis M.W., Sohl-Kielczynski B., Rosenmund C., Jorgensen E.M. Ultrafast endocytosis at mouse hippocampal synapses. Nature. 2013;504:242&#x2013;247. doi: 10.1038/nature12809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12809</ArticleId><ArticleId IdType="pmc">PMC3957339</ArticleId><ArticleId IdType="pubmed">24305055</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges-Merjane C., Kim O., Jonas P. Functional electron microscopy, &#x201c;flash and freeze&#x201d;, of identified cortical synapses in acute brain slices. Neuron. 2020;108:1011. doi: 10.1016/j.neuron.2020.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.11.015</ArticleId><ArticleId IdType="pmc">PMC7745710</ArticleId><ArticleId IdType="pubmed">33301719</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S., Trimbuch T., Rosenmund C. Synaptotagmin-1 drives synchronous Ca2+-triggered fusion by C2B-domain-mediated synaptic-vesicle-membrane attachment. Nat. Neurosci. 2018;21:33&#x2013;40. doi: 10.1038/s41593-017-0037-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0037-5</ArticleId><ArticleId IdType="pmc">PMC5742540</ArticleId><ArticleId IdType="pubmed">29230057</ArticleId></ArticleIdList></Reference><Reference><Citation>Imig C., Cooper B.H. 3D analysis of synaptic ultrastructure in arganotypic hippocampal slice culture by high-pressure freezing and electron tomography. Methods Mol. Biol. 2017;1538:215&#x2013;231. doi: 10.1007/978-1-4939-6688-2_15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-6688-2_15</ArticleId><ArticleId IdType="pubmed">27943193</ArticleId></ArticleIdList></Reference><Reference><Citation>Imig C., Lopez-Murcia F.J., Maus L., Garcia-Plaza I.H., Mortensen L.S., Schwark M., Schwarze V., Angibaud J., Nagerl U.V., Taschenberger H., et al. Ultrastructural imaging of activity-dependent synaptic membrane-trafficking events in cultured brain slices. Neuron. 2020;108:843&#x2013;860.e8. doi: 10.1016/j.neuron.2020.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.09.004</ArticleId><ArticleId IdType="pmc">PMC7736621</ArticleId><ArticleId IdType="pubmed">32991831</ArticleId></ArticleIdList></Reference><Reference><Citation>Maus L., Lee C., Altas B., Sertel S.M., Weyand K., Rizzoli S.O., Rhee J., Brose N., Imig C., Cooper B.H. Ultrastructural correlates of presynaptic functional heterogeneity in hippocampal synapses. Cell Rep. 2020;30:3632&#x2013;3643.e8. doi: 10.1016/j.celrep.2020.02.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.02.083</ArticleId><ArticleId IdType="pmc">PMC7090384</ArticleId><ArticleId IdType="pubmed">32187536</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto K. Freeze-fracture replica electron microscopy combined with SDS digestion for cytochemical labeling of integral membrane proteins. Application to the immunogold labeling of intercellular junctional complexes. J. Cell Sci. 1995;108:3443&#x2013;3449. doi: 10.1242/jcs.108.11.3443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.108.11.3443</ArticleId><ArticleId IdType="pubmed">8586656</ArticleId></ArticleIdList></Reference><Reference><Citation>Masugi-Tokita M., Shigemoto R. High-resolution quantitative visualization of glutamate and GABA receptors at central synapses. Curr. Opin. Neurobiol. 2007;17:387&#x2013;393. doi: 10.1016/j.conb.2007.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2007.04.012</ArticleId><ArticleId IdType="pubmed">17499496</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobius W., Cooper B., Kaufmann W.A., Imig C., Ruhwedel T., Snaidero N., Saab A.S., Varoqueaux F. Electron microscopy of the mouse central nervous system. Methods Cell Biol. 2010;96:475&#x2013;512. doi: 10.1016/S0091-679X(10)96020-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0091-679X(10)96020-2</ArticleId><ArticleId IdType="pubmed">20869535</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Belmonte A., Aguado C., Alfaro-Ruiz R., Itakura M., Moreno-Martinez A.E., de la Ossa L., Molnar E., Fukazawa Y., Lujan R. Age-dependent shift of AMPA receptors from synapses to intracellular compartments in Alzheimer&#x2019;s disease: Immunocytochemical analysis of the CA1 hippocampal region in APP/PS1 transgenic mouse model. Front. Aging Neurosci. 2020;12:577996. doi: 10.3389/fnagi.2020.577996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.577996</ArticleId><ArticleId IdType="pmc">PMC7572859</ArticleId><ArticleId IdType="pubmed">33132900</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Belmonte A., Aguado C., Alfaro-Ruiz R., Moreno-Martinez A.E., de la Ossa L., Martinez-Hernandez J., Buisson A., Fruh S., Bettler B., Shigemoto R., et al. Reduction in the neuronal surface of post and presynaptic GABAB receptors in the hippocampus in a mouse model of Alzheimer.s disease. Brain Pathol. 2020;30:554&#x2013;575. doi: 10.1111/bpa.12802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12802</ArticleId><ArticleId IdType="pmc">PMC7317930</ArticleId><ArticleId IdType="pubmed">31729777</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Belmonte A., Aguado C., Alfaro-Ruiz R., Moreno-Martinez A.E., de la Ossa L., Martinez-Hernandez J., Buisson A., Shigemoto R., Fukazawa Y., Lujan R. Density of GABAB receptors is reduced in granule cells of the hippocampus in a mouse model of Alzheimer&#x2019;s disease. Int. J. Mol. Sci. 2020;21:2459. doi: 10.3390/ijms21072459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21072459</ArticleId><ArticleId IdType="pmc">PMC7177735</ArticleId><ArticleId IdType="pubmed">32252271</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittmayer C., Volcker E., Wacker I., Schroder R.R., Bachmann S. Modern field emission scanning electron microscopy provides new perspectives for imaging kidney ultrastructure. Kidney Int. 2018;94:625&#x2013;631. doi: 10.1016/j.kint.2018.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2018.05.017</ArticleId><ArticleId IdType="pubmed">30143069</ArticleId></ArticleIdList></Reference><Reference><Citation>Titze B., Genoud C. Volume scanning electron microscopy for imaging biological ultrastructure. Biol. Cell. 2016;108:307&#x2013;323. doi: 10.1111/boc.201600024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/boc.201600024</ArticleId><ArticleId IdType="pubmed">27432264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hylton R.K., Swulius M.T. Challenges and triumphs in cryo-electron tomography. iScience. 2021;24:102959. doi: 10.1016/j.isci.2021.102959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102959</ArticleId><ArticleId IdType="pmc">PMC8383006</ArticleId><ArticleId IdType="pubmed">34466785</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Busnadiego R. Cryo-Electron Tomography of the Mammalian Synapse. Methods Mol. Biol. 2018;1847:217&#x2013;224. doi: 10.1007/978-1-4939-8719-1_16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8719-1_16</ArticleId><ArticleId IdType="pubmed">30129020</ArticleId></ArticleIdList></Reference><Reference><Citation>Gipson P., Fukuda Y., Danev R., Lai Y., Chen D.H., Baumeister W., Brunger A.T. Morphologies of synaptic protein membrane fusion interfaces. Proc. Natl. Acad. Sci. USA. 2017;114:9110&#x2013;9115. doi: 10.1073/pnas.1708492114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708492114</ArticleId><ArticleId IdType="pmc">PMC5576828</ArticleId><ArticleId IdType="pubmed">28739947</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucic V., Fernandez-Busnadiego R., Laugks U., Baumeister W. Hierarchical detection and analysis of macromolecular complexes in cryo-electron tomograms using Pyto software. J. Struct. Biol. 2016;196:503&#x2013;514. doi: 10.1016/j.jsb.2016.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2016.10.004</ArticleId><ArticleId IdType="pubmed">27742578</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrod N., Vanhecke D., Laugks U., Stein V., Fukuda Y., Schaffer M., Baumeister W., Lucic V. Pleomorphic linkers as ubiquitous structural organizers of vesicles in axons. PLoS ONE. 2018;13:e0197886. doi: 10.1371/journal.pone.0197886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0197886</ArticleId><ArticleId IdType="pmc">PMC5986143</ArticleId><ArticleId IdType="pubmed">29864134</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.T., Tao C.L., Lau P.M., Zhou Z.H., Bi G.Q. Postsynaptic protein organization revealed by electron microscopy. Curr. Opin. Struct. Biol. 2019;54:152&#x2013;160. doi: 10.1016/j.sbi.2019.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2019.02.012</ArticleId><ArticleId IdType="pmc">PMC6753054</ArticleId><ArticleId IdType="pubmed">30904821</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuber B., Lucic V. Molecular architecture of the presynaptic terminal. Curr. Opin. Struct. Biol. 2019;54:129&#x2013;138. doi: 10.1016/j.sbi.2019.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2019.01.008</ArticleId><ArticleId IdType="pubmed">30925443</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlando M., Ravasenga T., Petrini E.M., Falqui A., Marotta R., Barberis A. Correlating Fluorescence and High-Resolution Scanning Electron Microscopy (HRSEM) for the study of GABAA receptor clustering induced by inhibitory synaptic plasticity. Sci. Rep. 2017;7:13768. doi: 10.1038/s41598-017-14210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14210-5</ArticleId><ArticleId IdType="pmc">PMC5653763</ArticleId><ArticleId IdType="pubmed">29061992</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip K.M., Fischer N., Paknia E., Chari A., Stark H. Atomic-resolution protein structure determination by cryo-EM. Nature. 2020;587:157&#x2013;161. doi: 10.1038/s41586-020-2833-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2833-4</ArticleId><ArticleId IdType="pubmed">33087927</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen P.S. The 2017 Nobel Prize in Chemistry: Cryo-EM comes of age. Anal. Bioanal. Chem. 2018;410:2053&#x2013;2057. doi: 10.1007/s00216-018-0899-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-018-0899-8</ArticleId><ArticleId IdType="pubmed">29423601</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Xu L., Guan F., Liu Y.T., Cui Y., Zhang Q., Zheng X., Bi G.Q., Zhou Z.H., Zhang X., et al. Cryo-EM structure of the human alpha5beta3 GABAA receptor. Cell Res. 2018;28:958&#x2013;961. doi: 10.1038/s41422-018-0077-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-018-0077-8</ArticleId><ArticleId IdType="pmc">PMC6123483</ArticleId><ArticleId IdType="pubmed">30140029</ArticleId></ArticleIdList></Reference><Reference><Citation>Phulera S., Zhu H., Yu J., Claxton D.P., Yoder N., Yoshioka C., Gouaux E. Cryo-EM structure of the benzodiazepine-sensitive alpha1beta1gamma2S tri-heteromeric GABAA receptor in complex with GABA. eLife. 2018;7:e39383. doi: 10.7554/eLife.39383.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.39383</ArticleId><ArticleId IdType="pmc">PMC6086659</ArticleId><ArticleId IdType="pubmed">30044221</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S., Noviello C.M., Teng J., Walsh R.M., Jr., Kim J.J., Hibbs R.E. Structure of a human synaptic GABAA receptor. Nature. 2018;559:67&#x2013;72. doi: 10.1038/s41586-018-0255-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0255-3</ArticleId><ArticleId IdType="pmc">PMC6220708</ArticleId><ArticleId IdType="pubmed">29950725</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.J., Gharpure A., Teng J., Zhuang Y., Howard R.J., Zhu S., Noviello C.M., Walsh R.M., Jr., Lindahl E., Hibbs R.E. Shared structural mechanisms of general anaesthetics and benzodiazepines. Nature. 2020;585:303&#x2013;308. doi: 10.1038/s41586-020-2654-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2654-5</ArticleId><ArticleId IdType="pmc">PMC7486282</ArticleId><ArticleId IdType="pubmed">32879488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.J., Hibbs R.E. Direct structural insights into GABAA receptor pharmacology. Trends Biochem. Sci. 2021;46:502&#x2013;517. doi: 10.1016/j.tibs.2021.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2021.01.011</ArticleId><ArticleId IdType="pmc">PMC8122054</ArticleId><ArticleId IdType="pubmed">33674151</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao C., Shen C., Li C., Shen D.D., Xu C., Zhang S., Zhou R., Shen Q., Chen L.N., Jiang Z., et al. Cryo-EM structures of inactive and active GABAB receptor. Cell Res. 2020;30:564&#x2013;573. doi: 10.1038/s41422-020-0350-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0350-5</ArticleId><ArticleId IdType="pmc">PMC7343782</ArticleId><ArticleId IdType="pubmed">32494023</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Fu Z., Frangaj A., Liu J., Mosyak L., Shen T., Slavkovich V.N., Ray K.M., Taura J., Cao B., et al. Structure of human GABAB receptor in an inactive state. Nature. 2020;584:304&#x2013;309. doi: 10.1038/s41586-020-2452-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2452-0</ArticleId><ArticleId IdType="pmc">PMC7725281</ArticleId><ArticleId IdType="pubmed">32581365</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaye H., Ishchenko A., Lam J.H., Han G.W., Xue L., Rondard P., Pin J.P., Katritch V., Gati C., Cherezov V. Structural basis of the activation of a metabotropic GABA receptor. Nature. 2020;584:298&#x2013;303. doi: 10.1038/s41586-020-2408-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2408-4</ArticleId><ArticleId IdType="pmc">PMC8020835</ArticleId><ArticleId IdType="pubmed">32555460</ArticleId></ArticleIdList></Reference><Reference><Citation>Papasergi-Scott M.M., Robertson M.J., Seven A.B., Panova O., Mathiesen J.M., Skiniotis G. Structures of metabotropic GABAB receptor. Nature. 2020;584:310&#x2013;314. doi: 10.1038/s41586-020-2469-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2469-4</ArticleId><ArticleId IdType="pmc">PMC7429364</ArticleId><ArticleId IdType="pubmed">32580208</ArticleId></ArticleIdList></Reference><Reference><Citation>Evenseth L.S.M., Gabrielsen M., Sylte I. The GABAB receptor-structure, ligand binding and drug development. Molecules. 2020;25:3093. doi: 10.3390/molecules25133093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25133093</ArticleId><ArticleId IdType="pmc">PMC7411975</ArticleId><ArticleId IdType="pubmed">32646032</ArticleId></ArticleIdList></Reference><Reference><Citation>Biermann B., Ivankova-Susankova K., Bradaia A., Abdel Aziz S., Besseyrias V., Kapfhammer J.P., Missler M., Gassmann M., Bettler B. The Sushi domains of GABAB receptors function as axonal targeting signals. J. Neurosci. 2010;30:1385&#x2013;1394. doi: 10.1523/JNEUROSCI.3172-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3172-09.2010</ArticleId><ArticleId IdType="pmc">PMC6633810</ArticleId><ArticleId IdType="pubmed">20107064</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice H.C., de Malmazet D., Schreurs A., Frere S., Van Molle I., Volkov A.N., Creemers E., Vertkin I., Nys J., Ranaivoson F.M., et al. Secreted amyloid-beta precursor protein functions as a GABABR1a ligand to modulate synaptic transmission. Science. 2019;363:6423. doi: 10.1126/science.aao4827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao4827</ArticleId><ArticleId IdType="pmc">PMC6366617</ArticleId><ArticleId IdType="pubmed">30630900</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi M., Nozumi M., Wu L.G., Zanacchi F.C., Katona I., Barna L., Xu P., Zhang M., Xue F., Boyden E. New observations in neuroscience using superresolution microscopy. J. Neurosci. 2018;38:9459&#x2013;9467. doi: 10.1523/JNEUROSCI.1678-18.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1678-18.2018</ArticleId><ArticleId IdType="pmc">PMC6209844</ArticleId><ArticleId IdType="pubmed">30381437</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson M.G. Surpassing the lateral resolution limit by a factor of two using structured illumination microscopy. J. Microsc. 2000;198:82&#x2013;87. doi: 10.1046/j.1365-2818.2000.00710.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2818.2000.00710.x</ArticleId><ArticleId IdType="pubmed">10810003</ArticleId></ArticleIdList></Reference><Reference><Citation>Demmerle J., Innocent C., North A.J., Ball G., Muller M., Miron E., Matsuda A., Dobbie I.M., Markaki Y., Schermelleh L. Strategic and practical guidelines for successful structured illumination microscopy. Nat. Protoc. 2017;12:988&#x2013;1010. doi: 10.1038/nprot.2017.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2017.019</ArticleId><ArticleId IdType="pubmed">28406496</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurmann B., Bermingham D.P., Kopeikina K.J., Myczek K., Yoon S., Horan K.E., Kelly C.J., Martin-de-Saavedra M.D., Forrest M.P., Fawcett-Patel J.M., et al. A novel role for the late-onset Alzheimer&#x2019;s disease (LOAD)-associated protein Bin1 in regulating postsynaptic trafficking and glutamatergic signaling. Mol. Psychiatry. 2020;25:2000&#x2013;2016. doi: 10.1038/s41380-019-0407-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0407-3</ArticleId><ArticleId IdType="pmc">PMC6785379</ArticleId><ArticleId IdType="pubmed">30967682</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosby K.C., Gookin S.E., Garcia J.D., Hahm K.M., Dell&#x2019;Acqua M.L., Smith K.R. Nanoscale subsynaptic domains underlie the organization of the inhibitory synapse. Cell Rep. 2019;26:3284&#x2013;3297.e3283. doi: 10.1016/j.celrep.2019.02.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.02.070</ArticleId><ArticleId IdType="pmc">PMC6529211</ArticleId><ArticleId IdType="pubmed">30893601</ArticleId></ArticleIdList></Reference><Reference><Citation>Hell S.W., Wichmann J. Breaking the diffraction resolution limit by stimulated emission: Stimulated-emission-depletion fluorescence microscopy. Opt. Lett. 1994;19:780&#x2013;782. doi: 10.1364/OL.19.000780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1364/OL.19.000780</ArticleId><ArticleId IdType="pubmed">19844443</ArticleId></ArticleIdList></Reference><Reference><Citation>Hell S.W. Far-field optical nanoscopy. Science. 2007;316:1153&#x2013;1158. doi: 10.1126/science.1137395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1137395</ArticleId><ArticleId IdType="pubmed">17525330</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Gao Y., Winblad B., Tjernberg L.O., Schedin-Weiss S. A super-resolved view of the Alzheimer&#x2019;s disease-related amyloidogenic pathway in hippocampal neurons. J. Alzheimers Dis. 2021;83:833&#x2013;852. doi: 10.3233/JAD-215008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-215008</ArticleId><ArticleId IdType="pmc">PMC8543249</ArticleId><ArticleId IdType="pubmed">34366358</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rossi P., Nomura T., Andrew R.J., Masse N.Y., Sampathkumar V., Musial T.F., Sudwarts A., Recupero A.J., Le Metayer T., Hansen M.T., et al. Neuronal BIN1 Regulates Presynaptic Neurotransmitter Release and Memory Consolidation. Cell Rep. 2020;30:3520&#x2013;3535.e7. doi: 10.1016/j.celrep.2020.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.02.026</ArticleId><ArticleId IdType="pmc">PMC7146643</ArticleId><ArticleId IdType="pubmed">32160554</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Jans D.C., Winblad B., Tjernberg L.O., Schedin-Weiss S. Neuronal A&#x3b2;42 is enriched in small vesicles at the presynaptic side of synapses. Life Sci. Alliance. 2018;1:e201800028. doi: 10.26508/lsa.201800028.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201800028</ArticleId><ArticleId IdType="pmc">PMC6238618</ArticleId><ArticleId IdType="pubmed">30456353</ArticleId></ArticleIdList></Reference><Reference><Citation>Shcherbakova D.M., Sengupta P., Lippincott-Schwartz J., Verkhusha V.V. Photocontrollable fluorescent proteins for superresolution imaging. Annu. Rev. Biophys. 2014;43:303&#x2013;329. doi: 10.1146/annurev-biophys-051013-022836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biophys-051013-022836</ArticleId><ArticleId IdType="pmc">PMC4254894</ArticleId><ArticleId IdType="pubmed">24895855</ArticleId></ArticleIdList></Reference><Reference><Citation>Schedin-Weiss S., Caesar I., Winblad B., Blom H., Tjernberg L.O. Super-resolution microscopy reveals gamma-secretase at both sides of the neuronal synapse. Acta Neuropathol. Commun. 2016;4:29. doi: 10.1186/s40478-016-0296-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0296-5</ArticleId><ArticleId IdType="pmc">PMC4818506</ArticleId><ArticleId IdType="pubmed">27036709</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanguneri S., Pramod R.T., Efimova N., Das D., Jose M., Svitkina T., Nair D. Characterization of nanoscale arganization of F-actin in morphologically distinct dendritic spines in vitro using supervised learning. eNeuro. 2019;6 doi: 10.1523/ENEURO.0425-18.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0425-18.2019</ArticleId><ArticleId IdType="pmc">PMC6709208</ArticleId><ArticleId IdType="pubmed">31311803</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Le Corronc H., Legendre P., Triller A., Specht C.G. Differential regulation of glycinergic and GABAergic nanocolumns at mixed inhibitory synapses. EMBO Rep. 2021;22:e52154. doi: 10.15252/embr.202052154.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202052154</ArticleId><ArticleId IdType="pmc">PMC8256292</ArticleId><ArticleId IdType="pubmed">34047007</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabner C.P., Jansen I., Neef J., Weiss T., Schmidt R., Riedel D., Wurm C.A., Moser T. Resolving the molecular architecture of the photoreceptor active zone by MINFLUX nanoscopy. bioRxiv. 2021 doi: 10.1101/2021.05.28.446138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.28.446138</ArticleId></ArticleIdList></Reference><Reference><Citation>Paasila P.J., Fok S.Y.Y., Flores-Rodriguez N., Sajjan S., Svahn A.J., Dennis C.V., Holsinger R.M.D., Kril J.J., Becker T.S., Banati R.B., et al. Ground state depletion microscopy as a tool for studying microglia-synapse interactions. J. Neurosci. Res. 2021;99:1515&#x2013;1532. doi: 10.1002/jnr.24819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24819</ArticleId><ArticleId IdType="pmc">PMC8251743</ArticleId><ArticleId IdType="pubmed">33682204</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt R., Weihs T., Wurm C.A., Jansen I., Rehman J., Sahl S.J., Hell S.W. MINFLUX nanometer-scale 3D imaging and microsecond-range tracking on a common fluorescence microscope. Nat. Commun. 2021;12:1478. doi: 10.1038/s41467-021-21652-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21652-z</ArticleId><ArticleId IdType="pmc">PMC7935904</ArticleId><ArticleId IdType="pubmed">33674570</ArticleId></ArticleIdList></Reference><Reference><Citation>Manley S., Gillette J.M., Lippincott-Schwartz J. Single-particle tracking photoactivated localization microscopy for mapping single-molecule dynamics. Methods Enzym. 2010;475:109&#x2013;120. doi: 10.1016/S0076-6879(10)75005-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(10)75005-9</ArticleId><ArticleId IdType="pmc">PMC3690942</ArticleId><ArticleId IdType="pubmed">20627155</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauerbeck A.D., Gangolli M., Reitz S.J., Salyards M.H., Kim S.H., Hemingway C., Gratuze M., Makkapati T., Kerschensteiner M., Holtzman D.M., et al. SEQUIN multiscale imaging of mammalian central synapses reveals loss of synaptic connectivity resulting from diffuse traumatic brain injury. Neuron. 2020;107:257&#x2013;273.e5. doi: 10.1016/j.neuron.2020.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.04.012</ArticleId><ArticleId IdType="pmc">PMC7381374</ArticleId><ArticleId IdType="pubmed">32392471</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev S., Babitt J.L. Overview of iron metabolism in health and disease. Hemodial. Int. 2017;21:S6&#x2013;S20. doi: 10.1111/hdi.12542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hdi.12542</ArticleId><ArticleId IdType="pmc">PMC5977983</ArticleId><ArticleId IdType="pubmed">28296010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane D.J.R., Ayton S., Bush A.I. Iron and Alzheimer&#x2019;s disease: An update on emerging mechanisms. J. Alzheimers Dis. 2018;64:S379&#x2013;S395. doi: 10.3233/JAD-179944.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-179944</ArticleId><ArticleId IdType="pubmed">29865061</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndayisaba A., Kaindlstorfer C., Wenning G.K. Iron in neurodegeneration&#x2014;Cause or consequence? Front. Neurosci. 2019;13:180. doi: 10.3389/fnins.2019.00180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00180</ArticleId><ArticleId IdType="pmc">PMC6405645</ArticleId><ArticleId IdType="pubmed">30881284</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulk M., Abdelmoula W.M., Nabuurs R.J.A., van der Graaf L.M., Mulders C.W.H., Mulder A.A., Jost C.R., Koster A.J., van Buchem M.A., Natte R., et al. Postmortem MRI and histology demonstrate differential iron accumulation and cortical myelin organization in early- and late-onset Alzheimer&#x2019;s disease. Neurobiol. Aging. 2018;62:231&#x2013;242. doi: 10.1016/j.neurobiolaging.2017.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.10.017</ArticleId><ArticleId IdType="pubmed">29195086</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulk M., Van Der Weerd L., Breimer W., Lebedev N., Webb A., Goeman J.J., Ward R.J., Huber M., Oosterkamp T.H., Bossoni L. Quantitative comparison of different iron forms in the temporal cortex of Alzheimer patients and control subjects. Sci. Rep. 2018;8:6898. doi: 10.1038/s41598-018-25021-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25021-7</ArticleId><ArticleId IdType="pmc">PMC5932027</ArticleId><ArticleId IdType="pubmed">29720594</ArticleId></ArticleIdList></Reference><Reference><Citation>Yumoto S., Nagai H., Matsuzaki H., Matsumura H., Tada W., Nagatsuma E., Kobayashi K. Aluminium incorporation into the brain of rat fetuses and sucklings. Brain Res. Bull. 2001;55:229&#x2013;234. doi: 10.1016/S0361-9230(01)00509-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0361-9230(01)00509-3</ArticleId><ArticleId IdType="pubmed">11470320</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen S.J., DiGiacomo P.S., Zeng Y., Goubran M., Chen Y., Rutt B.K., Born D., Vogel H., Sinclair R., Zeineh M.M. Correlative microscopy to localize and characterize iron deposition in Alzheimer&#x2019;s disease. J. Alzheimers Dis. Rep. 2020;4:525&#x2013;536. doi: 10.3233/ADR-200234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/ADR-200234</ArticleId><ArticleId IdType="pmc">PMC7835989</ArticleId><ArticleId IdType="pubmed">33532700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.T., Randall J.D., Cahill C.M., Eder P.S., Huang X., Gunshin H., Leiter L., McPhee J., Sarang S.S., Utsuki T., et al. An iron-responsive element type II in the 5&#x2032;-untranslated region of the Alzheimer&#x2019;s amyloid precursor protein transcript. J. Biol. Chem. 2002;277:45518&#x2013;45528. doi: 10.1074/jbc.M207435200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207435200</ArticleId><ArticleId IdType="pubmed">12198135</ArticleId></ArticleIdList></Reference><Reference><Citation>Boopathi S., Kolandaivel P. Fe2+ binding on amyloid beta-peptide promotes aggregation. Proteins. 2016;84:1257&#x2013;1274. doi: 10.1002/prot.25075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.25075</ArticleId><ArticleId IdType="pubmed">27214008</ArticleId></ArticleIdList></Reference><Reference><Citation>Duce J.A., Tsatsanis A., Cater M.A., James S.A., Robb E., Wikhe K., Leong S.L., Perez K., Johanssen T., Greenough M.A., et al. Iron-export ferroxidase activity of &#x3b2;-amyloid precursor protein is inhibited by zinc in Alzheimer&#x2019;s disease. Cell. 2010;142:857&#x2013;867. doi: 10.1016/j.cell.2010.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.08.014</ArticleId><ArticleId IdType="pmc">PMC2943017</ArticleId><ArticleId IdType="pubmed">20817278</ArticleId></ArticleIdList></Reference><Reference><Citation>Everett J., Brooks J., Lermyte F., O&#x2019;Connor P.B., Sadler P.J., Dobson J., Collingwood J.F., Telling N.D. Iron stored in ferritin is chemically reduced in the presence of aggregating Abeta(1-42) Sci Rep. 2020;10:10332. doi: 10.1038/s41598-020-67117-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67117-z</ArticleId><ArticleId IdType="pmc">PMC7316746</ArticleId><ArticleId IdType="pubmed">32587293</ArticleId></ArticleIdList></Reference><Reference><Citation>Belaidi A.A., Bush A.I. Iron neurochemistry in Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease: Targets for therapeutics. J. Neurochem. 2016;139((Suppl. S1)):179&#x2013;197. doi: 10.1111/jnc.13425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13425</ArticleId><ArticleId IdType="pubmed">26545340</ArticleId></ArticleIdList></Reference><Reference><Citation>Masaldan S., Bush A.I., Devos D., Rolland A.S., Moreau C. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Free Radic. Biol Med. 2019;133:221&#x2013;233. doi: 10.1016/j.freeradbiomed.2018.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.09.033</ArticleId><ArticleId IdType="pubmed">30266679</ArticleId></ArticleIdList></Reference><Reference><Citation>Langkammer C., Ropele S., Pirpamer L., Fazekas F., Schmidt R. MRI for iron mapping in Alzheimer&#x2019;s disease. Neurodegener. Dis. 2014;13:189&#x2013;191. doi: 10.1159/000353756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000353756</ArticleId><ArticleId IdType="pubmed">23942230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ropele S., Langkammer C. Iron quantification with susceptibility. NMR Biomed. 2017;30:e3534. doi: 10.1002/nbm.3534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.3534</ArticleId><ArticleId IdType="pubmed">27119601</ArticleId></ArticleIdList></Reference><Reference><Citation>Yumoto S., Kakimi S., Ishikawa A. Colocalization of aluminum and iron in nuclei of nerve cells in brains of patients with Alzheimer&#x2019;s disease. J. Alzheimers Dis. 2018;65:1267&#x2013;1281. doi: 10.3233/JAD-171108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-171108</ArticleId><ArticleId IdType="pmc">PMC6218123</ArticleId><ArticleId IdType="pubmed">30149443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal A. Iron in health and disease: An update. Indian J. Pediatr. 2020;87:58&#x2013;65. doi: 10.1007/s12098-019-03054-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-019-03054-8</ArticleId><ArticleId IdType="pubmed">31520313</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>